{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T16:20:43Z","timestamp":1785860443352,"version":"3.56.0"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1097\/01.ftd.0000199360.25755.20","type":"journal-article","created":{"date-parts":[[2006,4,19]],"date-time":"2006-04-19T04:09:42Z","timestamp":1145419782000},"page":"164-168","source":"Crossref","is-referenced-by-count":32,"title":["Comparison of the Reintroduced MEIA\u00ae Assay With HPLC-MS\/MS for the Determination of Whole-Blood Sirolimus From Transplant Recipients"],"prefix":"10.1097","volume":"28","author":[{"given":"Raymond G.","family":"Morris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Salm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona A.","family":"Wicks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Theodossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210129","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1097\/00007890-200110150-00001","article-title":"Rapamycin: clinical results and future opportunities","volume":"72","author":"Kahan","year":"2001","journal-title":"Transplantation"},{"issue":"B","key":"R2-3-20210129","doi-asserted-by":"crossref","first-page":"B101","DOI":"10.1016\/S0149-2918(00)89027-X","article-title":"Clinical pharmacokinetics and therapeutic drug monitoring of sirolimus","volume":"22","author":"McDonald","year":"2000","journal-title":"Clin Ther"},{"key":"R3-3-20210129","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0009-9120(98)00045-9","article-title":"Rapamune\u00ae (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression","volume":"31","author":"Sehgal","year":"1998","journal-title":"Clin Biochem"},{"key":"R4-3-20210129","doi-asserted-by":"crossref","first-page":"573","DOI":"10.2165\/00003088-200140080-00002","article-title":"Clinical pharmacokinetics of sirolimus","volume":"40","author":"Mahalati","year":"2001","journal-title":"Clin Pharmacokinet"},{"key":"R5-3-20210129","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/00007691-200410000-00001","article-title":"New insights into drug absorption","volume":"26","author":"Paine","year":"2004","journal-title":"Ther Drug Monit"},{"key":"R6-3-20210129","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1034\/j.1399-0012.2000.140201.x","article-title":"Therapeutic drug monitoring of sirolimus: correlations with efficacy and toxicity","volume":"14","author":"Kahan","year":"2000","journal-title":"Clin Transplant"},{"issue":"B","key":"R7-3-20210129","doi-asserted-by":"crossref","first-page":"B93","DOI":"10.1016\/S0149-2918(00)89026-8","article-title":"Toxicity and efficacy of sirolimus: relationship to whole-blood concentrations","volume":"22","author":"Meier-Kriesche","year":"2000","journal-title":"Clin Ther"},{"key":"R8-3-20210129","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1093\/clinchem\/47.7.1316","article-title":"HPLC assay with ultraviolet detection for therapeutic monitoring of sirolimus","volume":"47","author":"French","year":"2001","journal-title":"Clin Chem"},{"issue":"B","key":"R9-3-20210129","doi-asserted-by":"crossref","first-page":"B14","DOI":"10.1016\/S0149-2918(00)89019-0","article-title":"A practical guide to the analysis of sirolimus using high-performance liquid chromatography with ultraviolet detection","volume":"22","author":"Napoli","year":"2000","journal-title":"Clin Ther"},{"key":"R10-3-20210129","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0378-4347(00)00380-7","article-title":"Automated, fast and sensitive quantification of drugs in blood by liquid chromatography-mass spectrometry with on-line extraction: immunosuppressants","volume":"748","author":"Christians","year":"2000","journal-title":"J Chromatogr B Biomed Sci Appl"},{"key":"R11-3-20210129","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1093\/clinchem\/46.8.1179","article-title":"Validation of an assay for routine monitoring of sirolimus using HPLC with mass spectrometric detection","volume":"46","author":"Holt","year":"2000","journal-title":"Clin Chem"},{"key":"R12-3-20210129","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0378-4347(98)00371-5","article-title":"Quantitative analysis of sirolimus (rapamycin) in blood by high-performance liquid chromatography-electrospray tandem mass spectrometry","volume":"718","author":"Taylor","year":"1998","journal-title":"J Chromatogr B Biomed Appl"},{"key":"R13-3-20210129","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/01.ftd.0000164394.47520.12","article-title":"CEDIA\u00ae sirolimus assay compared with HPLC-MS\/MS and HPLC-UV in transplant recipient specimens","volume":"27","author":"Westley","year":"2005","journal-title":"Ther Drug Monit"},{"key":"R16-3-20210129","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1023\/A:1007669411738","article-title":"Bioanalytical method validation. A revisit with a decade of progress","volume":"17","author":"Shah","year":"2000","journal-title":"Pharm Res"},{"key":"R17-3-20210129","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","article-title":"Statistical methods for assessing agreement between two methods of clinical measurement","volume":"i","author":"Bland","year":"1986","journal-title":"Lancet"},{"key":"R18-3-20210129","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(95)91748-9","article-title":"Comparing methods of measurement: why plotting difference against standard method is misleading","volume":"346","author":"Bland","year":"1995","journal-title":"Lancet"},{"key":"R21-3-20210129","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1373\/clinchem.2004.043950","article-title":"Low hematocrit and serum albumin concentrations underlie the overestimation of tacrolimus concentrations by microparticle enzyme immunoassay versus liquid chromatography-tandem mass spectrometry","volume":"51","author":"Brown","year":"2005","journal-title":"Clin Chem"},{"key":"R22-3-20210129","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/00007691-200208000-00008","article-title":"Interference of hematocrit in the tacrolimus II microparticle enzyme immunoassay","volume":"24","author":"Kuzuya","year":"2002","journal-title":"Ther Drug Monit"},{"key":"R23-3-20210129","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/00007691-200306000-00001","article-title":"Tacrolimus measurement by microparticle enzyme immunoassay II","volume":"25","author":"Taylor","year":"2003","journal-title":"Ther Drug Monit"},{"issue":"B","key":"R24-3-20210129","doi-asserted-by":"crossref","first-page":"B71","DOI":"10.1016\/S0149-2918(00)89024-4","article-title":"The quantification of sirolimus by high-performance liquid chromatography-tandem mass spectrometry and microparticle enzyme immunoassay in renal transplantation","volume":"22","author":"Salm","year":"2000","journal-title":"Clin Ther"},{"key":"R25-3-20210129","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.transproceed.2004.12.207","article-title":"A microparticle enzyme immunoassay to measure sirolimus","volume":"37","author":"Holt","year":"2005","journal-title":"Transplant Proc"},{"issue":"Suppl","key":"R26-3-20210129","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/00007890-200407271-01284","article-title":"Muti-center evaluation of an immunoassay for the measurement of sirolimus on the Abbott IMx\u00ae analyzer","volume":"78","author":"Wilson","year":"2004","journal-title":"Transplantation"},{"issue":"Suppl","key":"R27-3-20210129","first-page":"A128","article-title":"Development and multi-site evaluation of an assay for sirolimus on the Abbott IMx\u00ae analyzer [abstract]","volume":"50","author":"Wilson","year":"2004","journal-title":"Clin Chem"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00019048-200603000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:25:33Z","timestamp":1785857133000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007691-200604000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1097\/01.ftd.0000199360.25755.20","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4]]}}}